REFERENCES
- Hogarty G, Ulrich R. The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions of psychosocial treatment. Journal of Psychiatric Research 1998; 32: 243–250.
- Hamer S, Haddad P. Adverse effects of antipsychotics as outcome measures. British Journal of Psychiatry 2007; 191 (Suppl. 50): 64–70.
- Perlick D, Rosenheck R, Clarkin J . Adverse effects of perceived stigma on social adaptation of persons diagnosed with bipolar disorder. Psychiatric Services 2001; 52: 1627–1632.
- Lambert T, Chapman L. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. Medical Journal of Australia 2004; 181: 544–548.
- Awad G, Voruganti L. New antipsychotics, compliance, quality of life, and subjective tolerability – Are patients better off? Canadian Journal of Psychiatry 3004; 49: 297–301.
- Moncrieff J, Cohen D, Mason J. The subjective experience of taking antipsychotic medication: a content analysis of internet data. Acta Psychiatrica Scandinavica 2009; 120: 102–111.
- Gray R, Rofail D, Allen J, Newey T. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. Journal of Advanced Nursing 2005; 52: 31–37.
- Walter G, DeLaroche A, Nerissa S . Side effects of second generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Australian Psychiatry 2008; 16: 253–262.